

| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 158.16 |
| Log P | RDKit | 1.62 |
| Topological polar surface area (Å2) | RDKit | 34.14 |
| Number of hydrogen bond acceptors | RDKit | 2 |
| Number of hydrogen bond donors | RDKit | 0 |
| Number of carbon atoms | RDKit | 10 |
| Number of heavy atoms | RDKit | 12 |
| Number of heteroatoms | RDKit | 2 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 0 |
| Stereochemical complexity | RDKit | 0 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 10 |
| Number of sp3 hybridized carbon atoms | RDKit | 0 |
| Shape complexity | RDKit | 0 |
| Number of rotatable bonds | RDKit | 0 |
| Number of aliphatic carbocycles | RDKit | 1 |
| Number of aliphatic heterocycles | RDKit | 0 |
| Number of aliphatic rings | RDKit | 1 |
| Number of aromatic carbocycles | RDKit | 1 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 1 |
| Total number of rings | RDKit | 2 |
| Number of saturated carbocycles | RDKit | 0 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 0 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 2 |

| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 0 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 2 |
| Ghose filter | RDKit | Failed |
| Veber filter | RDKit | Good |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Good |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.574551 |

| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.55 |
| Solubility class [ESOL] | SwissADME | Soluble |
| Solubility class [Silicos-IT] | SwissADME | Soluble |
| Blood Brain Barrier permeation | SwissADME | Yes |
| Gastrointestinal absorption | SwissADME | High |
| Log Kp (Skin permeation, cm/s) | SwissADME | -6.05 |
| Number of PAINS structural alerts | SwissADME | 1 |
| Number of Brenk structural alerts | SwissADME | 0 |
| CYP1A2 inhibitor | SwissADME | Yes |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | No |

| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_001937 | ENSG00000101224 | CDC25B | 994 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001939 | ENSG00000158402 | CDC25C | 995 | ChEMBL, NPASS |
| TAR_EXP_001935 | ENSG00000164045 | CDC25A | 993 | ChEMBL, NPASS |
| TAR_EXP_001125 | ENSG00000127445 | PIN1 | 5300 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001722 | ENSG00000181090 | EHMT1 | 79813 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000390 | ENSG00000142208 | AKT1 | 207 | ChEMBL, NPASS |
| TAR_EXP_000566 | ENSG00000092621 | PHGDH | 26227 | ChEMBL, NPASS |
| TAR_EXP_000350 | ENSG00000106546 | AHR | 196 | ChEMBL, NPASS |
| TAR_EXP_000095 | ENSG00000224143 | EHMT2 | 10919 | ChEMBL, NPASS |
| TAR_EXP_000766 | ENSG00000131203 | IDO1 | 3620 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000851 | ENSG00000189221 | MAOA | 4128 | ChEMBL, NPASS |
| TAR_EXP_000852 | ENSG00000069535 | MAOB | 4129 | ChEMBL, NPASS |
| TAR_EXP_000786 | ENSG00000177606 | JUN | 3725 | NPASS |
| TAR_EXP_001240 | ENSG00000169032 | MAP2K1 | 5604 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001551 | ENSG00000145335 | SNCA | 6622 | ChEMBL, NPASS |
| TAR_EXP_001609 | ENSG00000151090 | THRB | 7068 | NPASS |
| TAR_EXP_001618 | ENSG00000198900 | TOP1 | 7150 | ChEMBL, NPASS |
| TAR_EXP_001619 | ENSG00000131747 | TOP2A | 7153 | ChEMBL, NPASS |
| TAR_EXP_001665 | ENSG00000111424 | VDR | 7421 | NPASS |
| TAR_EXP_000966 | ENSG00000116044 | NFE2L2 | 4780 | ChEMBL, NPASS |
| TAR_EXP_001757 | ENSG00000164305 | CASP3 | 836 | ChEMBL |